Literature DB >> 15579566

Role of nitric oxide in tolerance to lipopolysaccharide in mice.

Mirela B Dias1, Maria C Almeida, Evelin C Carnio, Luiz G S Branco.   

Abstract

The injection of repeated doses of lipopolysaccharide (LPS) results in attenuation of the febrile response, which is called endotoxin tolerance. We tested the hypothesis that nitric oxide (NO) arising from inducible NO synthase (iNOS) plays a role in endotoxin tolerance, using not only pharmacological trials but also genetically engineered mice. Body core temperature was measured by biotelemetry in mice treated with NG-monomethyl-L-arginine (L-NMMA, 40 mg/kg; a nonselective NO synthase inhibitor) or aminoguanidine (AG, 10 mg/kg; a selective iNOS inhibitor) and in mice deficient in the iNOS gene (iNOS KO) mice. Tolerance to LPS was induced by means of three consecutive LPS (100 microg/kg) intraperitoneal injections at 24-h intervals. In wild-type mice, we observed a significant reduction of the febrile response to repeated administration of LPS. Injection of L-NMMA and AG markedly enhanced the febrile response to LPS in tolerant animals. Conversely, iNOS-KO mice repeatedly injected with LPS did not become tolerant to the pyrogenic effect of LPS. These data are consistent with the notion that NO modulates LPS tolerance in mice and that iNOS isoform is involved in NO synthesis during LPS tolerance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579566     DOI: 10.1152/japplphysiol.01243.2004

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  7 in total

1.  Temporal trends of circulating nitric oxide and pro-inflammatory cytokine responses ex vivo in intra-abdominal sepsis: results from a cohort study.

Authors:  Miriam Ojeda Ojeda; Hilev Larrondo Muguercia; Abel Magdariaga Figuerola; Alfredo Sánchez Valdivia; Ingrid Rodríguez Alonso; Carmen Valenzuela Silva; Elizeth García Iglesias; Emma Domínguez Alonso; Wim A Buurman; Manuel de Jesús Araña Rosaínz
Journal:  Inflamm Res       Date:  2010-10-26       Impact factor: 4.575

2.  Lipid A-mediated tolerance and cancer therapy.

Authors:  Cheryl E Rockwell; David C Morrison; Nilofer Qureshi
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  Motif prediction to distinguish LPS-stimulated pro-inflammatory vs. antibacterial macrophage genes.

Authors:  Rahul K Kollipara; Narayanan B Perumal
Journal:  Immunome Res       Date:  2010-09-21

4.  Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis.

Authors:  D Manno; M Puoti; L Signorini; G Lapadula; B Cadeo; L Soavi; G Paraninfo; R Allegri; G Cristini; P Viale; G Carosi
Journal:  Infection       Date:  2009-07-23       Impact factor: 3.553

Review 5.  Gaseous neurotransmitters and their role in anapyrexia.

Authors:  Luiz G S Branco; Kenia C Bicego; Evelin C Carnio; Quentin J Pittman
Journal:  Front Biosci (Elite Ed)       Date:  2010-06-01

6.  Endotoxin tolerance variation over 24 h during porcine endotoxemia: association with changes in circulation and organ dysfunction.

Authors:  Markus Castegren; Paul Skorup; Miklós Lipcsey; Anders Larsson; Jan Sjölin
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

7.  Lung protective ventilation induces immunotolerance and nitric oxide metabolites in porcine experimental postoperative sepsis.

Authors:  Jesper Sperber; Miklós Lipcsey; Anders Larsson; Anders Larsson; Jan Sjölin; Markus Castegren
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.